Vanderbilt scientist wins 2026 Joseph A. Vita Award for immune-hypertension research

Dr. Annet Kirabo will receive the 2026 Joseph A. Vita Award from the American Heart Association at its annual Scientific Sessions in Chicago this November, recognition for research that has fundamentally reframed how scientists understand the relationship between immune activation, inflammation, and high blood pressure. The award, presented annually to a researcher whose work has significantly advanced cardiovascular biology or health within the past five years, will be given during the opening session on November 7 at a meeting that draws thousands of cardiovascular researchers and clinicians from around the world.

Kirabo, a professor of medicine in the division of genetic medicine and clinical pharmacology at Vanderbilt Health, spent years investigating a question that had long puzzled the field: why does the immune system seem to play a role in driving hypertension? Her breakthrough came through studying lipid oxidation-derived protein adducts—proteins that have been altered when they bind to highly reactive molecules created during fat oxidation. She demonstrated that these altered proteins act as neoantigens, triggering the immune system's antigen-presenting cells and T-cell responses in ways that lead to vascular dysfunction and elevated blood pressure. The discovery essentially rewrote the textbook on how the immune system contributes to blood pressure regulation.

Building on that foundation, Kirabo's laboratory has identified specific therapeutic targets that could eventually lead to new treatments. Among them are isolevuglandins, reactive lipid molecules, and sodium-sensing pathways in immune cells—both areas where intervention might prevent or treat hypertension and related cardiovascular and kidney diseases. Her work combines immunology, vascular biology, genomics, metabolomics, and single-cell technologies, reflecting a multidisciplinary approach that has become increasingly common in translational research but remains demanding to execute well.

The scope of her output underscores the depth of her contributions. Kirabo has published more than 230 scientific articles, maintained sustained funding from the National Institutes of Health, and placed influential work in the American Heart Association's peer-reviewed journals. Her research spans the full arc from fundamental discovery—understanding disease mechanisms at the cellular level—to translational work aimed at developing treatments that could eventually reach patients. Manesh Patel, the American Heart Association's 2026-2027 volunteer president, described her work as a paradigm shift that has reshaped understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease.

Beyond the laboratory, Kirabo has been deeply embedded in the American Heart Association's volunteer structure since 2009. She has served on the Council on Hypertension Communications Committee since 2018, chairing it from 2022 to 2024, and joined the Council Operations Committee in 2024. She has reviewed research proposals for the organization since 2017, chaired scientific sessions multiple times, and served on the editorial board of Hypertension since 2018 and as an associate editor of Circulation Research since 2019. This combination of research excellence and institutional service is part of what the Vita Award recognizes.

Kirabo's path to this recognition began in Uganda, where she earned her veterinary medicine degree with honors from Makerere University. She then pursued graduate training in the United States, completing a master's degree in cell and molecular biology at St. Cloud State University in Minnesota and a doctorate in physiology and functional genomics at the University of Florida. Postdoctoral training in cardiovascular disease and inflammation at Vanderbilt followed, and she has remained there to build her independent research program. In her statement accepting the award, she emphasized that scientific discovery, mentorship, and advancing new treatments for cardiovascular disease have been the primary focus of her career. She has trained dozens of graduate students, postdoctoral fellows, and early-career investigators, many of whom have moved into faculty positions and independent research careers of their own.

The award is named after Joseph A. Vita, a late cardiovascular scientist who founded the Journal of the American Heart Association, the organization's open-access peer-reviewed publication. The award is selected by the editors-in-chief of the American Heart Association's 14 peer-reviewed scientific journals and celebrates research that transforms or changes the direction of cardiovascular science. For Kirabo, the recognition arrives as her work continues to influence investigators worldwide and as the therapeutic targets she has identified move closer to clinical testing.